Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002713 |
Chlorine |
Chlorine results in decreased expression of LPHN1 mRNA | decreases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of LPHN1 mRNA | affects cotreatment|increases expression | 18636392
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of LPHN1 mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
LPHN1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPHN1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of LPHN1 mRNA | decreases expression | 17557909
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of LPHN1 mRNA | affects cotreatment|increases expression | 18636392
|
C041786 |
palm oil |
palm oil results in increased expression of LPHN1 mRNA | increases expression | 18042831
|
D010269 |
Paraquat |
Paraquat affects the expression of LPHN1 mRNA | affects expression | 15493455
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPHN1 mRNA | affects cotreatment|increases expression | 17942748
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of LPHN1 mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin affects the expression of LPHN1 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.11 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.21 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
4.51 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.52 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.52 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
4.00 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.74 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.47 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.32 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
9.32 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.64 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.76 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.59 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.68 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 19460635 18985861 18775368 18316065 19232924 18558336 16609825 17507914 18396377 15238991 17157402 20603192 18940202 18177632 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.37 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.37 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.96 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.97 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.88 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.88 | 15634643 15136595 16935488 16264153 16826403 15939500 16595493 18695136 18382427 16096432 17983394 18234424 15993339 18628466 15994142 19526202 16115903 15668708 17369602 16322301 11325840 17426702 15567936 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.81 | 16777450 19059883 18417511 18315731 17626835 14754758 15516495 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.98 | 16183385 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.08 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.25 | 18059187 17876044 16023760 16234567 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.23 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.67 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.64 | 17308081 17351982 17519947 16651473 15476868 15792986 16364871 15811867 16731534 18627295 16109756 16278810 17131338 16242529 17329180 17928571 15505089 17974986 16269455 16612575 17007740 16952015 17924179 16455267 17382496 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.99 | 17334414 16243910 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.00 | 17333356 16919318 15861022 16105132 11677210 17681005 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 12621046 15340226 16354765 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.52 | 16575769 8888407 17688650 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.54 | 14966744 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.52 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.52 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.52 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.53 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.53 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.57 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.89 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.38 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.56 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.42 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
14.15 | 19551842 17967931 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.15 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.15 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.83 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.35 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.35 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
5.27 | 20016425 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.17 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.57 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.45 | 17150277 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.43 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.64 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.60 | 14766674 16244371 16879835 17888722 17875725 12587719 18006777 16330681 16495754 16144979 16244372 18674790 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.44 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.07 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.56 | 15147373 18501091 17606976 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.76 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.02 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.65 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.90 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
11.90 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.90 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.19 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.19 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.21 | 18457598 11836018 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.14 | 16775033 15369732 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.33 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.42 | 16085563 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 16294345 17596541 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.97 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.96 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.48 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.48 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.25 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.25 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.49 | 19066396 8266340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
4.06 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.56 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.56 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.56 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.58 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.93 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.78 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.13 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.31 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.12 | 17638057 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.37 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.67 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.03 | 17415656 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.24 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.01 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.01 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.98 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.15 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.85 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.34 | 15555623 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.32 | 16723640 17217161 18457598 11836018 20518802 21332399 18674790 20132043 19632207 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.25 | 15930896 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.87 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.87 | 15451049 15824117 11445065 12911755 16510128 11124998 16140633 11181820 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.65 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.35 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.42 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.42 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.87 | 18381685 18929643 18007984 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
11.87 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.69 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.69 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
17.69 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.17 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.53 | 16729912 16888761 15897917 16868541 18437689 15749863 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.17 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.55 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 11422049 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.97 | 16324872 17997886 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.44 | 17922066 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.48 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
4.09 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.27 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.99 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.36 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.15 | 18313854 15625365 17203757 16767912 17710206 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.44 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.03 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.85 | 17978042 11044598 15475178 14763951 16876388 3137016 11738929 1511512 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.93 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.93 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.78 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.21 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.80 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.30 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.50 | 16010429 17909728 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.82 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.50 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.71 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.44 | 17334414 17638931 17678736 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.89 | 16723640 |